No way. If Acadia had the ability to buy NEU (they dont). You...

First 1329 Last

Share
Profile

Follow
Tony barber

7,034 Posts.

757

22/02/25

16:06

Post #: 77978730
Share

Originally posted by What A Gas ↑

I could see a cash + script offer from Acadia as being potentially very attractive. It must be at least an option with the manner in which Acadia appear to be progressing.

With 100% ownership of 2591, it would form a huge part of their potential value, just as it now does with Neuren, but that value may be more truely assessed in the hands of an American biotech.

I would not be averse to a virtual transfer of my holdings to Acadia should a reasonable offer be made. They have done amazingly well with the Daybue commercialisation. In the hands of a major biotech 2591 would likely remain small fish in the overall picture for some time yet.

I am hoping for a satisfactory offer from them. We would likely no longer have to put up with the blatant manipulation we have been subjected to and which will likely continue for as long as we are 'going it alone'.

2591 has the potential to become a blockbuster and I would love an ongoing interest in it, with a company in which it was the major value driver. Acadia could be that company.

Expand

No way. If Acadia had the ability to buy NEU (they dont).
You can always choose to buy Acadia as an individual. You can do it right now.

It sounds like wanting your cake and eating it too.

NEU Price at posting: $13.27 Sentiment: Buy Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 1329 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.86		Change 1.320(10.5%)		Mkt cap ! $1.702B

Open	High	Low	Value	Volume
$12.96	$14.00	$12.91	$10.15M	742.0K

Buyers (Bids)

No.	Vol.	Price($)
21	793	$13.85

Sellers (Offers)

Price($)	Vol.	No.
$13.86	173	5

View Market Depth

No.	Vol.	Price($)
13	396	13.850
6	359	13.840
5	438	13.830
2	352	13.820
7	1668	13.810

Price($)	Vol.	No.
13.870	228	1
13.880	125	1
13.890	1732	6
13.900	1824	8
13.910	2094	6

Last trade - 13.19pm 26/06/2025 (20 minute delay)

NEU (ASX) Chart

No way. If Acadia had the ability to buy NEU (they dont). You...

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

No way. If Acadia had the ability to buy NEU (they dont). You...

Top Stories

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News